EverQuote, Inc. (EVER) Spending and interest coverage
- R&D / revenue · 12 months: Value 4.53%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.06%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 4.53% | Research and development expense / revenue. Period ending 2026-06-30. $34.22M ÷ $755.20M × 100 ≈ 4.53% |
| Stock-based compensation / revenue · 12 months | 3.06% | Share-based compensation / revenue. Period ending 2026-06-30. $23.13M ÷ $755.20M × 100 ≈ 3.06% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 34.22M USD | Research and Development Expense |
| Revenue | 755.20M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 23.13M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 83.07M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $34.22M | $755.20M | $23.13M | $83.07M | (m) | 4.53% | 3.06% | (m) | (m) |
| 2026-03-31 | $32.57M | $716.74M | $24.02M | $73.75M | (m) | 4.54% | 3.35% | (m) | (m) |
| 2025-12-31 | $31.50M | $692.52M | $24.30M | $58.34M | (m) | 4.55% | 3.51% | (m) | (m) |
| 2025-09-30 | $30.84M | $644.66M | $24.02M | $51.73M | (m) | 4.78% | 3.73% | (m) | (m) |
| 2025-06-30 | $30.92M | $615.25M | $22.74M | $45.86M | (m) | 5.03% | 3.70% | (m) | (m) |
| 2025-03-31 | $30.19M | $575.76M | $21.52M | $37.98M | (m) | 5.24% | 3.74% | (m) | (m) |
| 2024-12-31 | $29.55M | $500.19M | $20.61M | $31.75M | (m) | 5.91% | 4.12% | (m) | (m) |
| 2024-09-30 | $27.86M | $408.44M | $20.12M | $12.96M | (m) | 6.82% | 4.93% | (m) | (m) |
| 2024-06-30 | $26.10M | $318.92M | $20.32M | $-28.12M | (m) | 8.18% | 6.37% | (m) | (m) |
| 2024-03-31 | $26.51M | $269.77M | $22.11M | $-47.78M | (m) | 9.83% | 8.19% | (m) | (m) |
| 2023-12-31 | $27.59M | $287.92M | $24.10M | $-51.98M | (m) | 9.58% | 8.37% | (m) | (m) |
| 2023-09-30 | $29.09M | $320.52M | $25.91M | $-53.89M | (m) | 9.07% | 8.08% | (m) | (m) |
| 2023-06-30 | $30.65M | $368.74M | $27.50M | $-31.07M | (m) | 8.31% | 7.46% | (m) | (m) |
| 2023-03-31 | $31.44M | $402.67M | $27.96M | $-21.52M | (m) | 7.81% | 6.94% | (m) | (m) |
| 2022-12-31 | $31.71M | $404.13M | $28.99M | $-24.79M | (m) | 7.85% | 7.17% | (m) | (m) |
| 2022-09-30 | $33.12M | $417.89M | $29.43M | $-24.58M | (m) | 7.93% | 7.04% | (m) | (m) |
| 2022-06-30 | $34.55M | $422.23M | $30.54M | $-25.78M | (m) | 8.18% | 7.23% | (m) | (m) |
| 2022-03-31 | $35.35M | $425.37M | $30.03M | $-23.83M | (m) | 8.31% | 7.06% | (m) | (m) |
| 2021-12-31 | $35.73M | $418.51M | $30.02M | $-21.92M | (m) | 8.54% | 7.17% | (m) | (m) |
| 2021-09-30 | $34.97M | $413.74M | $29.15M | $-17.23M | (m) | 8.45% | 7.04% | (m) | (m) |
| 2021-06-30 | $33.86M | $396.15M | $28.00M | $-12.74M | (m) | 8.55% | 7.07% | (m) | (m) |
| 2021-03-31 | $31.78M | $369.39M | $27.16M | $-13.82M | (m) | 8.60% | 7.35% | (m) | (m) |
| 2020-12-31 | $29.66M | $346.94M | $24.18M | $-11.68M | (m) | 8.55% | 6.97% | (m) | (m) |
| 2020-09-30 | $27.10M | $323.44M | $21.45M | $-9.05M | (m) | 8.38% | 6.63% | (m) | (m) |
| 2020-06-30 | $24.55M | $300.58M | $17.52M | $-5.85M | (m) | 8.17% | 5.83% | (m) | (m) |
| 2020-03-31 | $21.99M | $277.94M | $14.51M | $-5.14M | (m) | 7.91% | 5.22% | (m) | (m) |
| 2019-12-31 | $20.21M | $248.81M | $12.72M | $-8.05M | (m) | 8.12% | 5.11% | (m) | (m) |
| 2019-09-30 | $18.94M | $214.79M | $12.50M | $-14.01M | (m) | 8.82% | 5.82% | (m) | (m) |
| 2019-06-30 | $17.47M | $189.43M | $11.82M | $-17.86M | (m) | 9.22% | 6.24% | (m) | (m) |
| 2019-03-31 | $16.24M | $174.85M | $9.30M | $-17.24M | (m) | 9.29% | 5.32% | (m) | (m) |
| 2018-12-31 | $14.17M | $163.35M | $7.12M | $-13.91M | $199.00K | 8.68% | 4.36% | -69.91× | Reported |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $135.22M | (m) | $-4.37M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $9.19M | $126.24M | $1.86M | $-4.69M | $382.00K | 7.28% | 1.47% | -12.27× | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.